Literature DB >> 27506827

Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.

L Cicchelero1, S Denies1, H Haers2, K Vanderperren2, E Stock2, L Van Brantegem3, H de Rooster4,5, N N Sanders1,5.   

Abstract

Interleukin 12 (IL-12) is a powerful immunostimulatory cytokine with a strong antitumoural activity. In this work, the immunological, anti-angiogenic and clinical effects of three consecutive intratumoural IL-12 electrogene therapy (EGT) treatments were evaluated in nine dogs with spontaneous cancer. In all the dogs, tumour biopsies and blood samples were taken prior, during and after the intratumoural IL-12 EGT (on days 1, 8, 35 and 1, 3, 8, 15, 35, respectively). An initial decrease in immune cells was followed by an increase above baseline 1-3 weeks after treatment initiation. Interestingly, the decrease in peripheral leukocytes 2 days after the first intratumoural IL-12 EGT coincided with erythema and tumour swelling. Transient increases of IL-12 and interferon γ were measured in the serum and the tumour tissue, whereas IL-10 transiently increased only in the serum. The effect of intratumoural IL-12 EGT on the levels of IL-24 and vascular endothelial growth factor in the sera and tumour biopsies differed per dog. Via contrast-enhanced ultrasound (US) (on days 1, 8 and 35), we demonstrated that intratumoural IL-12 EGT resulted in a significant decrease of the relative blood volume and blood flow speed in the tumour compared with baseline. Metastases were present in two dogs. In one of these dogs, IL-12 EGT of the primary tumour caused a transient partial regression of the metastases, but not of the primary tumour. The second dog with metastases did not survive long enough to complete the entire treatment cycle. Despite encouraging immunostimulatory and anti-angiogenic effects after intratumoural IL-12 EGT, no clinically relevant outcomes were observed in this study, as persistent tumour regression could not be obtained. On the other hand, the laboratory and US results hold great promise for combinatorial strategies of intratumoural IL-12 EGT with conventional antitumour (immuno)therapies.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  angiogenesis; contrast-enhanced ultrasound; electroporation; gene transfer; immune stimulation; interleukin 12; spontaneous tumours

Mesh:

Substances:

Year:  2016        PMID: 27506827     DOI: 10.1111/vco.12255

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  16 in total

1.  Cell-Specific Requirements for STAT Proteins and Type I IFN Receptor Signaling Discretely Regulate IL-24 and IL-10 Expression in NK Cells and Macrophages.

Authors:  Djeneba Dabitao; Christian M Hedrich; Fengying Wang; Vimvara Vacharathit; Jay H Bream
Journal:  J Immunol       Date:  2018-02-07       Impact factor: 5.422

Review 2.  Localized Interleukin-12 for Cancer Immunotherapy.

Authors:  Khue G Nguyen; Maura R Vrabel; Siena M Mantooth; Jared J Hopkins; Ethan S Wagner; Taylor A Gabaldon; David A Zaharoff
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

Review 3.  Vector engineering, strategies and targets in cancer gene therapy.

Authors:  Vijayata Singh; Nusrat Khan; Giridhara R Jayandharan
Journal:  Cancer Gene Ther       Date:  2021-04-15       Impact factor: 5.987

Review 4.  Recent clinical trials of cancer immunogene therapy in companion animals.

Authors:  Liliana M E Finocchiaro; Gerardo C Glikin
Journal:  World J Exp Med       Date:  2017-05-20

Review 5.  Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy.

Authors:  Hong-My Nguyen; Kirsten Guz-Montgomery; Dipongkor Saha
Journal:  Cells       Date:  2020-02-10       Impact factor: 6.600

6.  Results of Dynamic Contrast-Enhanced Ultrasound Correlate With Treatment Outcome in Canine Neoplasia Treated With Electrochemotherapy and Interleukin-12 Plasmid Electrotransfer.

Authors:  Maja Brloznik; Simona Kranjc Brezar; Nina Boc; Tanja Knific; Maja Cemazar; Nina Milevoj; Gregor Sersa; Natasa Tozon; Darja Pavlin
Journal:  Front Vet Sci       Date:  2021-05-20

7.  Tumor perfusion evaluation using dynamic contrast-enhanced ultrasound after electrochemotherapy and IL-12 plasmid electrotransfer in murine melanoma.

Authors:  Maja Brloznik; Nina Boc; Maja Cemazar; Gregor Sersa; Masa Bosnjak; Simona Kranjc Brezar; Darja Pavlin
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

8.  Combination of Suicide and Cytokine Gene Therapies as Surgery Adjuvant for Canine Mammary Carcinoma.

Authors:  Liliana M E Finocchiaro; Agustina I M Spector; Lucrecia Agnetti; M Florencia Arbe; Gerardo C Glikin
Journal:  Vet Sci       Date:  2018-08-03

Review 9.  Ultrasound-mediated microbubble destruction: a new method in cancer immunotherapy.

Authors:  Jiawei Tu; Hui Zhang; Jinsui Yu; Chun Liufu; Zhiyi Chen
Journal:  Onco Targets Ther       Date:  2018-09-12       Impact factor: 4.147

10.  Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis.

Authors:  Shanawaz M Ghouse; Hong-My Nguyen; Praveen K Bommareddy; Kirsten Guz-Montgomery; Dipongkor Saha
Journal:  Front Oncol       Date:  2020-03-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.